Median dose was 10 mg/day. All patients with depot formulations (N = 15) were included in the >10 mg/day group. c Young adults: age 16–24 years; adults: age 25–64 years; elderly: age 65–82 years. d International Classification of Diseases-10: organic disorders, anxiety, personality...
Aripiprazole intra- muscular depot as maintenance treatment in patients with schizophrenia: a 52-week multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2012; 73: 617–624. 9 Fleischhacker WW, Sanchez R, Perry PP, Jin N, Peters-Strickland T, Johnson BR et al. ...
By study end, a quarter of patients had stopped taking Aripiprazole Depot due to ineffectiveness, side effects or patient request. Conclusion Aripriprazole Lauroxil 400鈥痬g depot was safe, effective and well tolerated. Side effects manifestations should prompt full evaluations and dose reduction ...